JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients
Open Journal of Blood Diseases · 2012
DOI: 10.4236/ojbd.2012.22004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Blood Diseases, 2012. Verfasst von Mamdooh Gari und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gari, M., Al-Sayes, F., Ahmed, F., Peerzada, A. A., Abuzenadah, A., Mira, L. S., Al-Qahtani, M., Dallol, A., Chaudhary, A., Mahnashi, M., & Damanhouri, G. (2012). JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients. Open Journal of Blood Diseases. https://doi.org/10.4236/ojbd.2012.22004
Vancouver
Gari M, Al-Sayes F, Ahmed F, Peerzada AA, Abuzenadah A, Mira LS, et al. JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients. Open Journal of Blood Diseases. 2012. doi:10.4236/ojbd.2012.22004
BibTeX
@article{Gari2012,
author = {Gari, Mamdooh and Al-Sayes, Fatin and Ahmed, Farid and Peerzada, Abdul Ali and Abuzenadah, Adel and Mira, Lubna S. and Al-Qahtani, Mohammed and Dallol, Ashraf and Chaudhary, Adeel and Mahnashi, Mohammed and Damanhouri, Ghazi},
title = {JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients},
journal = {Open Journal of Blood Diseases},
year = {2012},
doi = {10.4236/ojbd.2012.22004}
}
EUVIMED